Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Our e-services for applications, projects and assessments close on Thursday 25 April at 4:30pm because of system upgrades. We expect to open them again on Friday 26 April at 8am the latest.

Organic Bioelectronics enables patient-control of medical treatment

Reference number
Coordinator SICS EAST SWEDISH ICT AB - SICS East Swedish ICT
Funding from Vinnova SEK 500 000
Project duration April 2016 - December 2016
Status Completed
Venture Challenge-Driven Innovation – Stage 1 initiation

Purpose and goal

The project had three goals: to select the appropriate medical indication for the development of the first product, to create a development plan for this product for the project´s next phase, as well as to form an adequate consortium to maximise the chances to succeed with development. These three goals we have achieved. Contacts with industry have confirmed strong interest in pioneering technologies, such as ours, that facilitate individualized digitized healthcare, both in a holistic perspective but also, more importantly, for the identified indications.

Expected results and effects

The scientists involved have for 10 years had cooperation with physicians in many specialty areas. Based on this, and new contacts, we have identified 4 areas where our technology can solve significant clinical problems. Regulatory evaluation proposed the relief of chronic peripheral pain to be the easiest for early successful proof-of-concept. Clinical researchers at Region Östergötland have been engaged. Goal for the next phase is to have approval for a clinical research study where clinicians specialized in pain defines the requirements for the performance of the prototype.

Planned approach and implementation

Four workshops were planned and held. Joint planning and unambiguous responsibilities gave great transparency and basis for consensus. Weekly meetings were planned and carried out as the project leader´s contact with the partner representatives. We have succeeded in linking high-end clinical research centres as partners (Region Östergötland) for the next phase. We have established cooperation with stakeholders for additional indications, and are now formalizing cooperation with two foreign entities. The industry shows interest, and we believe in a signed agreement shortly.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 25 November 2019

Reference number 2016-00692

Page statistics